Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2167-2173

  Yang, Qi ^a   Lu, Jiafeng ^a   Wang, Shengqin ^a   Li, Hailin ^a   Ge, Qinyu ^a   Lu, Zuhong ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Circulating microRNA; High throughput sequencing technology; Preeclampsia

Indexed keywords

MICRORNA;

AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE TECHNOLOGY; GENETIC DATABASE; HUMAN; MOLECULAR GENETICS; MOLECULAR LIBRARY; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; RNA GENE; RNA ISOLATION; RNA PROCESSING; RNA SEQUENCE; SEQUENCE ANALYSIS; UPREGULATION;

CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; PRE-ECLAMPSIA; PREGNANCY;

EID: 80053619518     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.07.029     Document Type: Article

References (32)

1. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
4. Melkonyan H.S., Feaver W.J., Meyer E., et al. Transrenal nucleic acids: from proof of principle to clinical tests. Ann N Y Acad Sci 2008, 1137:73-81.
5. Gilad S., Meiri E., Yogev Y., et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008, 3:e3148.
6. Murata K., Yoshitomi H., Tanida S., et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2010, 12:R86.
7. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518.
8. Wang K., Zhang S., Marzolf B., et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 2009, 106:4402-4407.
9. Chim S.S., Shing T.K., Hung E.C., et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008, 54:482-490.
10. Ai J., Zhang R., Li Y., et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010, 391:73-77.
11. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127:118-126.
12. Zhao H., Shen J., Medico L., Wang D., Ambrosone C.B., Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010, 5:e13735.
13. Chen X., Ba Y., Ma L., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
14. Lawrie C.H., Gal S., Dunlop H.M., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141:672-675.
15. Wang G.K., Zhu J.Q., Zhang J.T., et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010, 31:659-666.
16. Coppee J.-Y. Do DNA microarrays have their future behind them?. Microbes Infect 2008, 10:1067-1071.
17. Tian G., Yin X., Luo H., Xu X., Bolund L., Zhang X. Sequencing bias: comparison of different protocols of microRNA library construction. BMC Biotechnol 2010, 10:64.
18. Johansen S.D., Karlsen B.O., Furmanek T., et al. RNA deep sequencing of the Atlantic cod transcriptome. Comp Biochem Physiol Part D Genomics Proteomics 2011, 6:18-22.
19. Redman C.W. Current topic: pre-eclampsia and the placenta. Placenta 1991, 12:301-308.
20. Sunanda G.V., Johanson R. Pre-eclampsia, diagnosis and treatment. Expert Opin Pharmacother 2001, 2:1817-1824.
21. Hertig A., Liere P. New markers in preeclampsia. Clin Chim Acta 2010, 411:1591-1595.
22. Conde-Agudelo A., Villar J., Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004, 104:1367-1391.
23. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
24. Schroeder B.M. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am Fam Physician 2002, 66:330-331.
25. Pineles B.L., Romero R., Montenegro D., et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 2007, 261:e261-266.
26. Zhu X.M., Han T., Sargent I.L., Yin G.W., Yao Y.Q. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol 2009, 200(661):e661-667.
27. Hu Y., Li P., Hao S., Liu L., Zhao J., Hou Y. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med 2009, 47:923-929.
28. Johansen S.D., Karlsen B.O., Furmanek T., et al. RNA deep sequencing of the Atlantic cod transcriptome. Comp Biochem Physiol Part D Genomics Proteomics 2011, 6:18-22.
29. http://www.targetscan.org/.
30. http://www.mir2disease.org/.
31. Ji R., Cheng Y., Yue J., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007, 100:1579-1588.
32. Hertig A., Liere P. New markers in preeclampsia. Clin Chim Acta 2010, 411:1591-1595.